TITLE

A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

AUTHOR(S)
Fouque, D.; Kalantar-Zadeh, K.; Kopple, J.; Cano, N.; Chauveau, P.; Cuppari, L.; Franch, H.; Guarnieri, G.; Ikizler, T. A.; Kaysen, G.; Lindholm, B.; Massy, Z.; Mitch, W.; Pineda, E.; Stenvinkel, P.; Trevinho-Becerra, A.; Wanner, C.
PUB. DATE
February 2008
SOURCE
Kidney International;Feb2008, Vol. 73 Issue 4, p391
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The recent research findings concerning syndromes of muscle wasting, malnutrition, and inflammation in individuals with chronic kidney disease (CKD) or acute kidney injury (AKI) have led to a need for new terminology. To address this need, the International Society of Renal Nutrition and Metabolism (ISRNM) convened an expert panel to review and develop standard terminologies and definitions related to wasting, cachexia, malnutrition, and inflammation in CKD and AKI. The ISRNM expert panel recommends the term ‘protein–energy wasting’ for loss of body protein mass and fuel reserves. ‘Kidney disease wasting’ refers to the occurrence of protein–energy wasting in CKD or AKI regardless of the cause. Cachexia is a severe form of protein–energy wasting that occurs infrequently in kidney disease. Protein–energy wasting is diagnosed if three characteristics are present (low serum levels of albumin, transthyretin, or cholesterol), reduced body mass (low or reduced body or fat mass or weight loss with reduced intake of protein and energy), and reduced muscle mass (muscle wasting or sarcopenia, reduced mid-arm muscle circumference). The kidney disease wasting is divided into two main categories of CKD- and AKI-associated protein–energy wasting. Measures of chronic inflammation or other developing tests can be useful clues for the existence of protein–energy wasting but do not define protein–energy wasting. Clinical staging and potential treatment strategies for protein–energy wasting are to be developed in the future.Kidney International (2008) 73, 391–398; doi:10.1038/sj.ki.5002585; published online 19 December 2007
ACCESSION #
28724620

 

Related Articles

  • Renal failure in lymphoma. Coggins, Cecil H. // Kidney International;Jun1980, Vol. 17 Issue 6, p847 

    Examines renal failure in lymphoma. Obstruction, infiltration and rupture of various portions of the urinary tract; Occurrence of amyloidosis or glomerulonephritis; Renal vein compression.

  • The management of CKD: A look into the future. Khwaja, A.; El Kossi, M.; Floege, J.; El Nahas, M. // Kidney International;Dec2007, Vol. 72 Issue 11, p1316 

    The increasing global prevalence of chronic kidney disease (CKD) and end-stage renal disease with the associated spiraling cost has profound public health and economic implications. This has made slowing the progression of CKD, a major health-care priority. CKD is invariably characterized by...

  • Renal and hepatic uptake of biologically active intact parathyroid hormone. Heidbreder, Ekkehard; Götz, Rüdiger; Schafferhans, Klauss; Heidland, August // Kidney International Supplement;Oct1987, Issue 22, pS-221 

    Examines renal and hepatic uptake of biologically active intact parathyroid hormone (PTH). Influence of diseased kidneys on the peripheral metabolism of the intact hormone; Relationship between peripheral-venous PTH concentrations and total serum calcium in acute renal failure; Percentage renal...

  • Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial. Macdougall, Iain C. // Trials;2007, Vol. 8, p35 

    Background: Anaemia is a common complication of chronic kidney disease and prevalence increases with declining renal function. Renal anaemia has significant implications for the well-being and quality of life of patients and impacts on morbidity and mortality. Anaemia can be well managed by...

  • VITAL STATISTICS.  // Independent Nurse;3/2/2009, p6 

    The article presents statistics related kidney diseases worldwide, including the number of people with chronic kidney disease, the percentage of people affected in countries worldwide and the percentage of those who realised they have chronic kidney disease.

  • Partial hypoxanthine-guanine phosphoribosyltransferase deficiency presenting as acute renal failure. Cherian, Sarah; Crompton, Charles H. // Pediatric Nephrology;Dec2005, Vol. 20 Issue 12, p1811 

    Hyperuricemia and secondary urate nephropathy are uncommon in the paediatric setting outside of tumour lysis syndrome. We describe the case of a 12-year-old boy who presented at 3 years of age with acute renal failure. The cause of this remained unknown until the development of uric acid renal...

  • The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease.  // BMC Nephrology;2011, Vol. 12 Issue 1, p41 

    The article focuses on a study which analyzes the prevalence and management of hypertension and associated chronic kidney disease (CKD) by ethnicity. The study was conducted on 49,203 adults with hypertension. The study found that 9.5% was the crude prevalence of hypertension. The study...

  • Prevention of renal failure: The Malaysian experience. Lai Seong Hooi; Hin Seng Wong; Zaki Morad // Kidney International Supplement;Apr2005, Issue 94, p70 

    Prevention of renal failure: The Malaysian experience. Renal replacement therapy in Malaysia has shown exponential growth since 1990. The dialysis acceptance rate for 2003 was 80 per million population, prevalence 391 per million population. There are now more than 10,000 patients on dialysis....

  • Parenteral nutrition in patients with renal failure -- Guidelines on Parenteral Nutrition, Chapter 17. Druml, W.; Kierdorf, H. P. // GMS German Medical Science;2009, Vol. 7, p1 

    Partial EN (enteral nutrition) should always be aimed for in patients with renal failure that require nutritional support. Nevertheleß PN (parenteral nutrition) may be neceßary in renal failure in patient groups with acute or chronic renal failure (ARF or CRF) and additional acute diseases...

  • Landmark Papers in Nephrology.  // Journal of Renal Nursing;Jul2014, Vol. 6 Issue 4, p203 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics